Antibiotic Resistance Market Analysis
The antibiotic resistance market is likely touch USD 13,146 million at a 5.8% CAGR between 2019- 2025, as per the new Market Research Future’s antibiotic resistance statistics. Antibiotics are medicines that are used for preventing and treating bacterial infections. Antibiotic resistance takes place when the bacteria changes in response to the usage of such medicines. The bacteria become antibiotic-resistant and not humans. These bacteria then may infect humans and are difficult to treat in comparison to non-resistant bacteria. Along with antibiotic resistance, antimicrobial resistance too may take place. Antimicrobial drug resistance encompasses resistance to drugs for treating infections resulting from other microbes such as fungi, viruses, and parasites.
Get Free Sample @ https://www.marketresearchfuture.com/sample_request/8579
Numerous factors are adding to the antibiotic resistance market demand. Such factors, as revealed by the latest MRFR report, include increasing initiatives worldwide to control drug-resistance, rise in clinical developments of antibiotic resistance, increasing prevalence of infectious & chronic disease, and growing antibiotic drug resistance infections.
On the contrary, the high medical cost may limit the antibiotic resistance industry growth over the forecast period.
Antibiotic Resistance Market Segmentation
The Market Research Future Report provides an inclusive segmental analysis of the antibiotic resistance market based on end user, pathogen, disease, and drug class.
By drug class, the antibiotic resistance market is segmented into oxazolidinones, lipoglycopeptides, tetracyclines, combination therapies, cephalosporins, and others. Others have again been segmented into vancomycin, sulfonamide, and others. Of these, combination therapies will lead the market over the forecast period for the rising use of such therapies for gram-negative infections, which have limited treatment.
By disease, the antibiotic resistance market is segmented into community-acquired bacterial pneumonia, hospital-acquired bacterial pneumonia/ventilator, acute bacterial skim & skin structure infections, clostridium difficile infections, complicated intra-abdominal infections, bloodstream infections, and complicated urinary tract infection. Of these, complicated urinary tract infections will dominate the market over the forecast period.
By pathogen, the antibiotic resistance market is segmented into campylobacter, pneumonia, clostridium difficile, pseudomonas aeruginosa, hemophilus influenza, enterococcus, acinetobacter, streptococcus pneumonia, staphylococcus aureus, and others. Others are again segmented into enterobacteriaceae, Neisseria gonorrhoeae, salmonella, and others. Of these, pneumonia will have the largest share in the market over the forecast period.
By end use, the antibiotic resistance market is segmented into research organizations, hospitals and clinics, and others. Others are again segmented into emergency care centers, nursing homes, and academic institutes. Of these, hospitals and clinics is predicted to have a major share in the market over the forecast period for the majority of the procedures and treatments being carried out in hospitals.
Antibiotic Resistance Market Regional Analysis
By region, the global antibiotic resistance market report covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period. Factors propelling the antibiotic resistance market growth in the region include rising incidence of infectious diseases, rising adoption of antibiotic resistance, and rapidly growing pharmaceutical sector.
The global antibiotic resistance market in Europe is predicted to hold the second-largest share during the forecast period for an increase in bacterial infections, rising incidence of infectious diseases, and increasing consumption of antibiotic resistance.
The global antibiotic resistance market in the APAC region is predicted to grow at a high CAGR over the forecast period for the increasing number of hospital-acquired infections and antibiotic-resistant infections.
The global antibiotic resistance market in the MEA is predicted to have healthy growth over the forecast period for the increasing consumption of antibiotic resistance and rising healthcare expenditure.
Antibiotic Resistance Market Key Players
Eminent players profiled in the global antibiotic resistance market report include Allecra Therapeutics (US), Procarta Biosystems (England), NEMESIS BIOSCIENCE LTD (UK), Entasis Therapeutics (US), Basilea Pharmaceutica Ltd. (Switzerland), Tetraphase Pharmaceuticals (US), Theravance Biopharma (UK), Seres Therapeutics (US), PARATEK Therapeutics (US), Nabriva Therapeutics plc (Ireland), MELINTA THERAPEUTICS, INC. (US), and Achaogen, Inc. (US). Industry players have incorporated strategies such as extensive research and development activities, strategic alliances, partnerships, acquisitions, mergers, new product development and launches, and collaborations to stay ahead in the competition.
Browse In-depth Market Research Report (199 pages) on Antibiotic Resistance Market @ https://www.marketresearchfuture.com/reports/antibiotic-resistance-market-8579
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
